Complexities of Rett Syndrome and MeCP2: Figure 1.
Open Access
- 1 June 2011
- journal article
- review article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 31 (22), 7951-7959
- https://doi.org/10.1523/jneurosci.0169-11.2011
Abstract
### Introduction 1Rett syndrome (RTT, MIM 312750), originally described by the Austrian pediatrician Andreas Rett, is an X-linked neurodevelopmental disorder that primarily affects girls at a frequency of 1:10,000 live female births ([Rett, 1966][1]; [Hagberg, 1985][2]; [Laurvick et al., 2006][3Keywords
This publication has 112 references indexed in Scilit:
- Rett syndrome: Revised diagnostic criteria and nomenclatureAnnals of Neurology, 2010
- Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse modelJournal of Molecular Medicine, 2010
- A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem CellsCell, 2010
- MeCP2 functions largely cell-autonomously, but also non-cell-autonomously, in neuronal maturation and dendritic arborization of cortical pyramidal neuronsExperimental Neurology, 2010
- Longevity in Rett Syndrome: Analysis of the North American DatabaseThe Journal of Pediatrics, 2010
- MeCP2 deficiency disrupts axonal guidance, fasciculation, and targeting by altering Semaphorin 3F functionMolecular and Cellular Neuroscience, 2009
- Modulation of dendritic spine development and plasticity by BDNF and vesicular trafficking: fundamental roles in neurodevelopmental disorders associated with mental retardation and autismJournal of Neurodevelopmental Disorders, 2009
- Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutationsNeurobiology of Disease, 2009
- Ube3a mRNA and protein expression are not decreased in Mecp2R168X mutant miceBrain Research, 2007
- Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNACell, 1992